From May 1, 2023 to July 31, 2023, the company has repurchased 101,000 shares, representing 0.75% for $0.6 million. With this, the company has completed the repurchase of 115,000 shares, representing 0.85% for $0.68 million under the buyback announced on April 5, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.01 USD | -0.20% | +3.09% | -10.85% |
1st Jan change | Capi. | |
---|---|---|
-10.85% | 68.1M | |
+16.71% | 44.48B | |
+43.23% | 40.57B | |
-7.92% | 38.82B | |
+33.09% | 32.22B | |
-7.10% | 27.84B | |
+14.46% | 26.79B | |
+46.73% | 14.31B | |
+34.07% | 12.7B | |
-7.61% | 11.23B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.